CTLA-4 expression on tregs is needed for suppression of autoimmune uveitis

被引:0
|
作者
Minjun Ahn [1 ]
John Dostal [1 ]
Priya Hegde [1 ]
Darren J. Lee [1 ]
机构
[1] University of Massachusetts Chan Medical School,Department of Ophthalmology and Visual Sciences
关键词
Autoimmune uveitis; Ocular immune privilege; Treg cells; CTLA-4;
D O I
10.1038/s41598-025-02816-z
中图分类号
学科分类号
摘要
Uveitis is a leading cause of blindness in the world and autoimmune uveitis is an ocular tissue specific autoimmune disease. Utilizing experimental autoimmune uveitis (EAU), we can interrogate different immune responses in the mouse that are relevant to the human disease. cytotoxic T-lymphocyte antigen 4 (CTLA-4) is an immune checkpoint molecule that has different roles depending on the target tissue. In this work we investigate the role of CTLA-4 on CD4 T cells in ocular tissue during EAU. We find that CTLA-4 is needed for both the severity of disease but also timely resolution of disease. Regulatory T cells (Tregs) that emerge in the spleen during resolution of EAU require CTLA-4 to suppress disease, but ocular Tregs that emerge in the eye do not require CTLA-4 to suppress disease. This report provides an additional understanding of CTLA-4 on Tregs that is specific for ocular tissue. The implications of this work are that circulating Tregs in uveitis patients may require CTLA-4 to suppress ocular inflammation but once in the eye the function of CTLA-4 is dispensable. 
引用
收藏
相关论文
共 50 条
  • [1] Tregs in Autoimmune Uveitis
    Huang, Zhaohao
    Li, Wenli
    Su, Wenru
    T REGULATORY CELLS IN HUMAN HEALTH AND DISEASES, 2021, 1278 : 205 - 227
  • [2] EXPRESSION OF CD152 (CTLA-4) IN CHILDREN WITH AUTOIMMUNE THYROIDITIS AND+49 A/G POLYMORPHISM OF EXON 1 OF THE CTLA-4 GENE
    Kucharska, A. M.
    Gorska, E.
    Wasik, M.
    Pyrzak, B.
    Demkow, U.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 60 : 77 - 80
  • [3] Augmentation of CTLA-4 expression by wortmannin: involvement of lysosomal sorting properties of CTLA-4
    Oki, S
    Kohsaka, T
    Azuma, M
    INTERNATIONAL IMMUNOLOGY, 1999, 11 (09) : 1563 - 1571
  • [4] CTLA-4 in autoimmune diseases – a general susceptibility gene to autoimmunity?
    OP Kristiansen
    ZM Larsen
    F Pociot
    Genes & Immunity, 2000, 1 : 170 - 184
  • [5] Current understanding of CTLA-4: from mechanism to autoimmune diseases
    Hossen, Md Munnaf
    Ma, Yanmei
    Yin, Zhihua
    Xia, Yuhao
    Du, Jing
    Huang, Jim Yi
    Huang, Jennifer Jin
    Zou, Linghua
    Ye, Zhizhong
    Huang, Zhong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
    Klocke, Katrin
    Sakaguchi, Shimon
    Holmdahl, Rikard
    Wing, Kajsa
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (17) : E2383 - E2392
  • [7] Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases
    Fernandez-Mestre, Mercedes
    Sanchez, Karen
    Balbas, Omar
    Gendzekhzadze, Ketevan
    Ogando, Violeta
    Cabrera, Mayra
    Layrisse, Zulay
    HUMAN IMMUNOLOGY, 2009, 70 (07) : 532 - 535
  • [8] CTLA-4 (CD152) and its involvement in autoimmune disease
    Holmberg, D
    Cilio, CM
    Lundholm, M
    Motta, V
    AUTOIMMUNITY, 2005, 38 (03) : 225 - 233
  • [9] CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders
    Pavkovic, M
    Georgievski, B
    Cevreska, L
    Spiroski, M
    Efremov, DG
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 72 (02) : 147 - 149
  • [10] CTLA-4 in autoimmune diseases - a general susceptibility gene tc autoimmunity?
    Kristiansen, OP
    Larsen, ZM
    Pociot, F
    GENES AND IMMUNITY, 2000, 1 (03) : 170 - 184